Albumin 20% Biotest 50 ml.
Restoration and maintainance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropiate.
Albumin 20% GCC 50 ml.
Restoration and maintainance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropiate.
Haemoctin Sdh 250 IU.
Treatment and prophylaxis of bleeding in patients with haemophilia A
Haemoctin Sdh 500 IU.
Treatment and prophylaxis of bleeding in patients with haemophilia A
I.V.-Globulin Sn Inj 100 ml. (5,000 mg)/Vial
1. Hypogammaglobulinemia
2. Idiopathic Thrombocytopenic Purpura (ITP)
3. Guillain-Barre Syndrome
4. Kawasaki Syndrome
I.V.-Globulin Sn Inj 50 ml. (2,500 mg)/Vial
1. Hypogammaglobulinemia
2. Idiopathic Thrombocytopenic Purpura (ITP)
3. Guillain-Barre Syndrome
4. Kawasaki Syndrome
Intratect 100 ml. 5 g.
Replacement therapy in:
a) Primary immunodeficiency syndromes
b) Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
c) Children with congenital AIDS and recurrent infections
Immunomodulation
a) Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count
b) Guillain Barré syndrome
c) Kawasaki disease
Allogeneic bone marrow transplantation
Intratect 200 ml. 10 g.
Replacement therapy in:
a) Primary immunodeficiency syndromes
b) Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
c) Children with congenital AIDS and recurrent infections
Immunomodulation
a) Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count
b) Guillain Barré syndrome
c) Kawasaki disease
Allogeneic bone marrow transplantation
Pentaglobin 10 ml.
Adjuvant therapy of severe bacterial infections additional to antibiotic therapy.
Immunoglobulin substitution in immunocompromized patients.
Pentaglobin 50 ml.
Adjuvant therapy of severe bacterial infections additional to antibiotic therapy.
Immunoglobulin substitution in immunocompromized patients.